Hexagon Capital Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,163
| Closed | -$353K | – | 1172 |
|
|
2025
Q1 | $353K | Sell |
3,163
-77
| -2% | -$8.58K | 0.07% | 137 |
|
|
2024
Q4 | $315K | Sell |
3,240
-255
| -7% | -$24.8K | 0.06% | 149 |
|
|
2024
Q3 | $402K | Sell |
3,495
-65
| -2% | -$7.48K | 0.08% | 117 |
|
|
2024
Q2 | $379K | Sell |
3,560
-53
| -1% | -$5.64K | 0.08% | 126 |
|
|
2024
Q1 | $349K | Sell |
3,613
-241
| -6% | -$23.3K | 0.08% | 130 |
|
|
2023
Q4 | $389K | Buy |
3,854
+1,171
| +44% | +$118K | 0.09% | 114 |
|
|
2023
Q3 | $273K | Buy |
2,683
+154
| +6% | +$15.7K | 0.07% | 131 |
|
|
2023
Q2 | $255K | Buy |
2,529
+399
| +19% | +$40.3K | 0.07% | 137 |
|
|
2023
Q1 | $196K | Buy |
2,130
+160
| +8% | +$14.7K | 0.05% | 160 |
|
|
2022
Q4 | $179K | Sell |
1,970
-18
| -0.9% | -$1.63K | 0.05% | 160 |
|
|
2022
Q3 | $151K | Buy |
1,988
+485
| +32% | +$36.8K | 0.04% | 182 |
|
|
2022
Q2 | $127K | Buy |
1,503
+501
| +50% | +$42.3K | 0.04% | 227 |
|
|
2022
Q1 | $88K | Buy |
1,002
+97
| +11% | +$8.52K | 0.02% | 294 |
|
|
2021
Q4 | $79K | Hold |
905
| – | – | 0.02% | 294 |
|
|
2021
Q3 | $74K | Hold |
905
| – | – | 0.02% | 290 |
|
|
2021
Q2 | $83K | Hold |
905
| – | – | 0.02% | 265 |
|
|
2021
Q1 | $77K | Sell |
905
-173
| -16% | -$14.7K | 0.02% | 261 |
|
|
2020
Q4 | $101K | Hold |
1,078
| – | – | 0.03% | 189 |
|
|
2020
Q3 | $85K | Buy |
+1,078
| New | +$85K | 0.03% | 186 |
|